ASCO 2021 Wrap-Up - Breast Cancer

Conference Correspondent | June 14, 2021
Breast cancer survivors may test positive for pathogenic germline variants 10 years after their original diagnosis. Germline genetic testing may be an important tool for managing care.
Conference Correspondent | June 14, 2021
Improved understanding of potential risk factors associated with weight gain will allow identification of at-risk patients and intervention for improved outcomes.
Conference Correspondent | June 14, 2021
The VA CARES program provides coordinated cancer care for veterans prescribed oral antineoplastic therapies who may lack access to comprehensive medication management resources.
Conference Correspondent | June 14, 2021
Alpelisib plus fulvestrant combination therapy improves progression-free survival while maintaining effectiveness in patients with HR-positive/HER2-negative advanced breast cancer in a French early access study.
Conference Correspondent | June 14, 2021
Metabolic syndrome is associated with poor prognosis in patients with breast cancer. Identifying potential risk factors for metabolic syndrome may improve outcomes in these women.

Results 1 - 6 of 6

Subscribe to the Journal of Oncology Navigation & Survivorship®

To sign up for our print publication or e-newsletter, please enter your contact information below.

  • First Name *
    Last Name *
    Profession or Role
    Primary Specialty or Disease State
  • Please enter your mailing address.

    Address Line 2
    Zip Code